marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSY) and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial

INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal…

GT Biopharma Inc. (GTBP) Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company

Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief…

Tilray Brands, Inc. (TLRY) Introduces New Naturally Flavoured CBG Infused Cannabis Beverages

Tilray Introduces New Naturally Flavoured CBG Infused Cannabis Beverages Tilray Brands, Inc.…